Management of Gliomas: Overview of the Latest Technological Advancements and Related Behavioral Drawbacks

Behavioural Neurology
L GanauM Ganau

Abstract

The advancements in basic sciences and the availability of sophisticated technological aids to surgical removal of gliomas have led over the last few years to the rise of innovative surgical strategies, the identification of better prognostic/predictive biomolecular factors, and the development of novel drugs and all are meant to profoundly impact the outcome of patients diagnosed with these aggressive tumours. Unfortunately, the treatment protocols available nowadays still confer only a small survival advantage at a potentially high cost in terms of overall well-being. In this review we identified the potential and limits of the most promising research trends in the management of glioma patients, also highlighting the related externalities. Finally, we focused our attention on the imbalance between the technical and behavioral aspects pertinent to this research area, which ultimately represent the two sides of the same coin.

References

Jan 25, 2005·Journal of Neurosurgery·Gabriela SimonováRoman Liscák
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 25, 2008·Methods in Molecular Biology·Hiroko Ohgaki
Jul 17, 2009·Current Opinion in Oncology·Hugues Duffau
Dec 19, 2009·Neurology·Kristen L TriebelDaniel C Marson
Dec 25, 2009·International Journal of Computer Assisted Radiology and Surgery·A SboarinaC Cordiano
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel C MarsonLouis B Nabors
Aug 20, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R SoffiettiW Wick
Sep 30, 2010·Journal of Neuro-oncology·Andrea TalacchiMassimo Gerosa
May 4, 2011·Brain Structure & Function·Igor Lima MaldonadoHugues Duffau
Oct 8, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cagdas YavasFadil Akyol
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil K AaronsonMartin Klein
Nov 3, 2011·Journal of Neurosurgery·Nader SanaiMitchel S Berger
Dec 14, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Eefje M SizooMartin J B Taphoorn
Dec 14, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cagdas YavasFadil Akyol
Jan 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Vinai GondiWolfgang A Tomé
Apr 10, 2012·World Neurosurgery·Bente Sandvei SkeiePaal-Henning Pedersen
Sep 14, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Alasdair G RooneyRobin Grant
Sep 28, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M Ganau
Dec 10, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Lisa Millgård SagbergOle Solheim
Mar 5, 2014·Journal of Neurology·Anna Rita GiovagnoliAmerigo Boiardi
May 7, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Asgeir S JakolaOle Solheim
May 21, 2014·Cancer Science·Yutaka KondoKeiko Shinjo
Jun 1, 2014·Acta neurochirurgica·Esther J J HabetsMartin J B Taphoorn
Jul 19, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Linda DirvenUNKNOWN EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry)
Aug 15, 2014·Journal of Neuro-oncology·Katherine B PetersLee W Jones
Dec 4, 2014·Journal of Oncology Practice·Jeffrey J RaizerJune M McKoy
Dec 4, 2014·Journal of Neuro-oncology·Chika R NwachukwuNadia N Laack
Dec 4, 2014·Cancer Treatment and Research·Orin Bloch
Jan 9, 2015·Annals of Medicine and Surgery·Sayed Samed TalibiOsama Aweid
Jan 15, 2015·International Journal of Radiation Oncology, Biology, Physics·Chad G RusthovenBrian D Kavanagh
Jan 20, 2015·Neurosurgical Focus·Masayuki NittaYoshikazu Okada
Feb 2, 2015·Patient Education and Counseling·Georgia K B HalkettAnna K Nowak
Feb 5, 2015·Swiss Medical Weekly·Philippe SchuchtAndreas Raabe

❮ Previous
Next ❯

Citations

Apr 21, 2018·Journal of Magnetic Resonance Imaging : JMRI·Sanjeev ChawlaS Ali Nabavizadeh
Jul 16, 2016·Molecular Pharmacology·Fernanda B MorroneNatália F Nicoletti

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
imaging techniques

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medicinal Research Reviews
J Pallarés-TrujilloJ M Argilés
Nature Genetics
Andrea Gallavotti, Robert J Schmidt
WMJ : Official Publication of the State Medical Society of Wisconsin
Barry Blackwell
Singapore Medical Journal
Weekitt Kittisupamongkol
Journal of Medical Education
F L STONE
© 2021 Meta ULC. All rights reserved